Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


michael.ellis@well.ox.ac.uk

Michael Ellis

Research Assistant

I am working alongside Dr Irina Stefana to investigate the mechanisms underlying the loss of pancreatic beta-cell function seen in type 1 diabetes. The primary focus of this project is investigating the role of the microtubule-associated protein Tau, alongside the various phosphorylated variants, attempting to determine the mechanisms driving this beta-cell failure.

Originally from York, I completed a BSc (Hons) in Medical Sciences and an MSc in Molecular Medicine, both from the University of Leeds. During this time, I investigated the epigenetic regulation of drug-resistant chronic myeloid leukaemia and the associated mechanisms. I joined the DIL Group in August 2019 as a Laboratory Technician working within the Sample Processing Team. I was in this position for nine months before joining the Ludwig Institute for Cancer Research in April 2020 as a Research Assistant. In this position, I investigated how p53 influences the development of pancreatic cancer using a murine model. Finally, I re-joined the Todd-Wicker Group in April 2021 as a Research Assistant.